Also trades as: ICCM.TA (TLV) · $vol 0M
ICCM NASDAQ
IceCure Medical Ltd
1W: -5.0%
1M: -37.0%
3M: -60.7%
YTD: -63.8%
1Y: -78.1%
3Y: -81.9%
$0.24
+0.01 (+3.29%)
Weekly Expected Move ±11.5%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$15.0M
52W Range0.215-1.4
Volume1,398,251
Avg Volume580,819
Beta1.63
Dividend—
Analyst Ratings
Company Info
CEOEyal Shamir
Employees64
SectorHealthcare
IndustryMedical - Devices
IPO Date2021-08-26
Websiteicecure-medical.com
7 HaâEshel Street
Caesarea 3079504
IL
Caesarea 3079504
IL
972 4 623 0333
About IceCure Medical Ltd
IceCure Medical Ltd, a medical device company, engages in the research, development, and commercialization of medical devices for cryoablation (freezing) of tumors in the human body. It offers ProSense system, a cryoablation solution for the treatment of breast tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.
Latest News
12 Health Care Stocks Moving In Tuesday's After-Market Session
IceCure (ICCM) Q1 2026 Earnings Transcript
IceCure Medical Ltd. (ICCM) Reports Q1 Loss, Lags Revenue Estimates
IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America
Earnings Scheduled For May 12, 2026
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Tsimerman Ronen | 0 | — | 2026-05-17 | |
| Peleg Meir | 0 | — | 2026-05-17 | |
| Muchnik Naum | 0 | — | 2026-04-12 | |
| Malca Yonatan | 0 | — | 2026-03-18 | |
| Huang Yang | 0 | — | 2026-03-18 |